180 related articles for article (PubMed ID: 31546618)
1. Upregulation of Lysyl Oxidase Expression in Vitreous of Diabetic Subjects: Implications for Diabetic Retinopathy.
Subramanian ML; Stein TD; Siegel N; Ness S; Fiorello MG; Kim D; Roy S
Cells; 2019 Sep; 8(10):. PubMed ID: 31546618
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.
El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M
Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase.
Coral K; Angayarkanni N; Gomathy N; Bharathselvi M; Pukhraj R; Rupak R
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3607-12. PubMed ID: 19369240
[TBL] [Abstract][Full Text] [Related]
5. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
Kim D; Mecham RP; Nguyen NH; Roy S
Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
[TBL] [Abstract][Full Text] [Related]
7. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
8. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy.
Praidou A; Klangas I; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S
Curr Eye Res; 2009 Feb; 34(2):152-61. PubMed ID: 19219687
[TBL] [Abstract][Full Text] [Related]
9. Altered oxylipin levels in human vitreous indicate imbalance in pro-/anti-inflammatory homeostasis in proliferative diabetic retinopathy.
Zhao T; Wang Y; Guo X; Li H; Jiang W; Xiao Y; Deng B; Sun Y
Exp Eye Res; 2022 Jan; 214():108799. PubMed ID: 34687725
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-A (VEGF-A) in vitreous fluid of patients with proliferative diabetic retinopathy.
Kant S; Seth G; Anthony K
Ann Ophthalmol (Skokie); 2009; 41(3-4):170-3. PubMed ID: 20214050
[TBL] [Abstract][Full Text] [Related]
11. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
12. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
[TBL] [Abstract][Full Text] [Related]
15. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
16. Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival: Implications for Diabetic Retinopathy.
Kim D; Lee D; Trackman PC; Roy S
Am J Pathol; 2019 Oct; 189(10):1945-1952. PubMed ID: 31537300
[TBL] [Abstract][Full Text] [Related]
17. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy.
Murata M; Noda K; Fukuhara J; Kanda A; Kase S; Saito W; Ozawa Y; Mochizuki S; Kimura S; Mashima Y; Okada Y; Ishida S
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4055-62. PubMed ID: 22618595
[TBL] [Abstract][Full Text] [Related]
18. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
[TBL] [Abstract][Full Text] [Related]
19. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
20. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
